Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
about
Monitoring of anti-cancer treatment with (18)F-FDG and (18)F-FLT PET: a comprehensive review of pre-clinical studiesPET/CT in Oncology: Current Status and Perspectives.Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer.Monte Carlo simulations of absorbed dose in a mouse phantom from 18-fluorine compounds.Molecular imaging in cancer treatment.Preliminary study on the correlation between grading and histology of solitary pulmonary nodules and contrast enhancement and [18F]fluorodeoxyglucose standardised uptake value after evaluation by dynamic multiphase CT and PET/CT.Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinib.Comparison of the diagnostic performance of (18)F-fluorothymidine versus (18)F-fluorodeoxyglucose positron emission tomography on pulmonary lesions: A meta analysis.Limits of [18F]-FLT PET as a biomarker of proliferation in oncologyImaging of treatment response to the combination of carboplatin and paclitaxel in human ovarian cancer xenograft tumors in mice using FDG and FLT PETApplications of molecular imaging.Gradient-based delineation of the primary GTV on FLT PET in squamous cell cancer of the thoracic esophagus and impact on radiotherapy planning.Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-AnalysisNovel Approaches to Imaging Tumor Metabolism3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response.Correlation between Semi-Quantitative (18)F-FDG PET/CT Parameters and Ki-67 Expression in Small Cell Lung CancerAssessment of cellular proliferation in tumors by PET using 18F-ISO-1.In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PETThe role of positron emission tomography in the management of non-small cell lung cancer.On the impact of functional imaging accuracy on selective boosting IMRTPET and SPECT Imaging of Tumor Biology: New Approaches towards Oncology Drug Discovery and Development.A pilot study of 4'-[methyl-11C]-thiothymidine PET/CT for detection of regional lymph node metastasis in non-small cell lung cancer.Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription.Novel molecular imaging in lung and pleural diseases.A systemic review of PET and biology in lung cancerMolecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer.PET/CT in therapy evaluation of patients with lung cancer.Novel positron emission tomography radiotracers in brain tumor imaging.Novel positron emission tomography tracer distinguishes normal from cancerous cells.FDG and Beyond.New PET/CT criterion for nodal staging in non-small cell lung cancer: measurement of the ratio of section area of standard uptake values ≥2.5/lymph node section area.Imaging colon cancer response following treatment with AZD1152: a preclinical analysis of [18F]fluoro-2-deoxyglucose and 3'-deoxy-3'-[18F]fluorothymidine imagingImpact of the definition of peak standardized uptake value on quantification of treatment response.Role of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in the Evaluation of Head and Neck Carcinoma.F-18-FDG and C-11-Choline Positron Emission Tomography in Human Esophago-Gastric Cancer: Prediction of Response to Therapy.Correlations of (18)F-fluorothymidine uptake with pathological tumour size, Ki-67 and thymidine kinase 1 expressions in primary and metastatic lymph node colorectal cancer foci.Comparison of ( 18 ) F-FLT PET and ( 18 ) F-FDG PET for detection of cervical lymph node metastases in head and neck cancers.Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined 18F-FDG and 18F-FLT PET/CT imaging.Can multimodality imaging using 18F-FDG/18F-FLT PET/CT benefit the diagnosis and management of patients with pulmonary lesions?Standardized Uptake Values Derived from 18F-FDG PET May Predict Lung Cancer Microvessel Density and Expression of KI 67, VEGF, and HIF-1α but Not Expression of Cyclin D1, PCNA, EGFR, PD L1, and p53.
P2860
Q26778463-5693C1EC-8B33-4625-BB5B-C41B71CDC365Q33665109-ADC91EB0-CA79-4837-A334-7ED9F07103FBQ33750115-24DEECDB-F573-4A4E-8997-EAEF083C594FQ34425601-2F77E410-A540-49AE-9DE0-328CD84C2692Q34496670-B1099E8C-B567-4F5C-8BF5-4D86995B3140Q34538956-68BAF4D4-2F45-4D31-B7D0-C6D2B9C2637DQ34544677-67721A74-3FA5-4825-8497-A6B5BA7E8618Q34607468-29C4BEE7-A047-4D0F-A4F0-5A259102C227Q34648592-ADC7DC61-E40F-4885-B8B5-88558E320235Q35081130-E9900B44-9E16-4229-8D93-4BF41CD3D44EQ35082412-86029F13-BED6-4568-B64B-40AE687EF2E3Q35092030-467C3B74-04E9-42F6-9655-E39CC8B6C644Q35650841-FAE88650-10F3-4365-837B-ED88A37911BFQ35700192-2499F130-9A33-4AE2-862D-0DEBFC83A68DQ36217442-9687C68C-6081-4C81-9E90-643A166F3FBEQ36604990-0924EDE8-8BAC-46B8-98BD-9B02948696B5Q36960962-17CF35D2-A7E6-460E-A479-71579310AE87Q37077354-BCC35A10-B4F0-416F-9911-3C1210884DD1Q37210598-F344934C-4D03-4C7D-B291-C296A4E323F7Q37332199-D2F2F82C-0F92-446F-B64E-A3E60E47E784Q37374442-DC2E702E-224E-4253-9A15-D49C2319579AQ37686084-65CCC5AE-D4AB-46F7-966D-131B4329EF3BQ37847721-0776C6E2-B397-49D4-8218-4ACCEB65F52AQ37927164-50BC220C-A1BB-44D5-8FDC-ACCA3E2909E1Q37929599-AD0B95D8-6578-42A7-8E58-165B09D69C52Q38134094-ECCE7149-8156-420B-8D35-6476C36BAFB0Q38202189-BBD817F9-C6F9-485D-A1C1-20F4420806C8Q38670632-0DA4248E-2611-4584-91F1-F89FD3091C52Q38673771-BBF1459B-13CA-461D-9062-1690BA1B566AQ38869438-4E9523F1-EF98-43F8-8F2F-223B832A270BQ38947114-78D0AFBC-36EE-4CE3-8321-0AA1470157D6Q39606309-F3789B5C-0A23-4F02-A931-6BB061162BA5Q42092531-5175B5CA-0BDA-4E72-B471-FD1086F441E4Q42376455-24BB3B5C-D0E7-4001-B8BE-E367B27ECE2AQ47098382-A78F3A84-341A-4959-AE20-F0A6B526A6ACQ47442773-43E8980C-1358-48BC-B40A-21A7596EFA8BQ51321761-FC35B148-0B76-47F2-9980-16802F71C58CQ52597352-423D03A9-DCD2-461D-B41C-08C7329E63A0Q53267271-2EAF5E71-CE76-4AB3-A2EC-25B3BC69E410Q55492679-7039F1AE-7FBA-4F4E-8585-F871AE20772D
P2860
Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Evaluation of thoracic tumors ...... -positron emission tomography.
@en
type
label
Evaluation of thoracic tumors ...... -positron emission tomography.
@en
prefLabel
Evaluation of thoracic tumors ...... -positron emission tomography.
@en
P2093
P356
P1433
P1476
Evaluation of thoracic tumors ...... -positron emission tomography.
@en
P2093
Cecelia S Yap
Christiaan Schiepers
Johannes Czernin
Michael C Fishbein
Michael E Phelps
Robert B Cameron
Wolfgang A Weber
P304
P356
10.1378/CHEST.129.2.393
P407
P577
2006-02-01T00:00:00Z